Adventa Bhd

Adventa Bhd EBITDA Margin

Delisted

The EBITDA Margin of Adventa Bhd (ADVENTA.KL) as of Nov 3, 2026 is 6.13 %. In the previous year, EBITDA Margin was -25.82 % — a change of -123.75% (higher).

EBITDA Margin

6.13 %

YoY

-123.75%

Last updated:

EBITDA Margin of Adventa Bhd is 2024 6.13 % . EBITDA Margin of Adventa Bhd was 2023 -25.82 % . It decreases by -123.75% higher compared to the previous year.

The Adventa Bhd EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2017
5.62 MYR
Jan 1, 2018
-36.16 MYR
Jan 1, 2019
-37.28 MYR
Jan 1, 2020
10.97 MYR
Jan 1, 2021
8.24 MYR
Jan 1, 2022
-7.77 MYR
Jan 1, 2023
-25.82 MYR
Jan 1, 2024
6.13 MYR
The Adventa Bhd EBITDA Margin history
YEAREBITDA MarginYoY
6.13 %-123.75%
-25.82 %+232.44%
-7.77 %-194.32%
8.24 %-24.90%
10.97 %-129.41%
-37.28 %+3.11%
-36.16 %-742.91%
5.62 %-32.15%
8.29 %-33.36%
12.44 %-34.88%
19.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Adventa Bhd Stock analysis

What does Adventa Bhd do? Adventa Bhd. generates revenue through its Healthcare segment, which supplies medical products and services to hospitals, healthcare centers, and pharmacies. The company's subsidiaries, including Adventa Healthcare Sdn. Bhd. and PTM Progress Trading & Marketing Sdn. Bhd., contribute to this segment by distributing medical equipment, appliances, and disposal products, as well as providing storage and warehousing services. Nextech Med Pte. Ltd. operates as an investment holding subsidiary within the Corporate segment, supporting the group's strategic initiatives. The company serves healthcare institutions and pharmacies across its operational regions. Adventa Healthcare Sdn. Bhd. focuses on distributing medical and healthcare equipment, appliances, and disposal products to hospitals and healthcare centers, while PTM Progress Trading & Marketing Sdn. Bhd. offers storage and warehousing solutions for medical supplies. These services are provided under the company's Healthcare segment, which is the primary revenue driver. The Corporate segment, managed through Nextech Med Pte. Ltd., handles investment activities that support the group's overall strategy. The company's business model relies on its subsidiaries to deliver medical products and services to healthcare providers, with Adventa Healthcare Sdn. Bhd. acting as the main distributor and PTM Progress Trading & Marketing Sdn. Bhd. managing logistics. Nextech Med Pte. Ltd. functions as an investment holding entity within the Corporate segment, facilitating strategic investments without direct revenue generation from this subsidiary. Adventa Bhd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Adventa Bhd stock

EBITDA Margin of Adventa Bhd is 6.13 % in 2024.

EBITDA Margin of Adventa Bhd changed from -25.82 % to 6.13 %, representing a -123.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Adventa Bhd since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Adventa Bhd with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Adventa Bhd

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Adventa Bhd